Mostrar el registro sencillo del ítem
Pharmacovigilance of Psychoactive Medications in a Mexican Psychiatric Hospital
dc.contributor.author | Ortíz Ramírez, Mario | |
dc.date.accessioned | 2013-11-12T18:53:37Z | |
dc.date.available | 2013-11-12T18:53:37Z | |
dc.date.issued | 2011 | |
dc.identifier.uri | https://repository.uaeh.edu.mx/bitstream/handle/123456789/13984 | |
dc.description.abstract | Pharmacovigilance is defined as watchfulness in guarding against danger from drugs or providing for safety of drugs. It can also be a dedicated department whose role is to monitor toxicity and safety of drugs both in the developmental phase and post marketing. A working group on Pharmacovigilance aims to develop workable operating procedures for the publicly funded research community for reporting, monitoring and managing adverse reactions and events that will satisfy the requirements of the Medicines for Human Use (Clinical Trials) Regulations. It is also envisaged that the group will review and evaluate information from healthcare providers and patients on the adverse effects of medications, biological products, herbalism and traditional medicines. | es |
dc.language.iso | en | es |
dc.subject | Research Subject Categories::MEDICINE | es |
dc.title | Pharmacovigilance of Psychoactive Medications in a Mexican Psychiatric Hospital | es |
dc.type | Presentation | es |